Last edition
News about "Q2FY27 Financial Results"
Strides Pharma Science Reports 17 Percent Revenue Growth in Q2FY27
Strides Pharma reported consolidated revenue of INR 1,429.7 crore in Q2FY27, supported by growth in ex-US markets, while EBITDA reached INR 25.09 crore.
Q2FY27 Financial Results | 30/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members